Keyphrases
Chronic Hepatitis B
50%
Chronic Hepatitis B Patients
25%
Clinical Relapse
75%
Cumulative Incidence
25%
CXCL9
100%
End of Treatment
50%
Flow Cytometric Analysis
25%
Hazard Ratio
75%
HBeAg-negative Chronic Hepatitis B
100%
HBsAg Decline
25%
HBsAg Level
25%
HBsAg Loss
75%
Hepatitis B Surface Antigen (HBsAg)
25%
Immunological Biomarkers
50%
Immunological Indicators
100%
Immunological Outcomes
25%
IP-10
25%
Low Risk
25%
Multivariate Analysis
25%
Off-treatment
25%
Online Treatment
50%
Peginterferon
25%
Peginterferon Therapy
100%
Predictive Value
25%
Ropeginterferon alfa-2b
100%
T Cell Subsets
50%
Univariate Analysis
25%
Virological Marker
50%
Virological Relapse
75%
Virological Response
25%
Immunology and Microbiology
CXCL9
66%
HBsAg
100%
Hepatitis B
100%
Hepatitis B Antigen
100%
Hepatitis B(e) Antigen
100%
Peginterferon Alfa-2a
100%
Pegylated Interferon
83%
T Cell Subset
33%